dismiss

Mark your calendars: the next Clean Sweep Live Auction will be on Thursday, June 21st Click to view the full catalogue

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment

 

 

More Industry Headlines

Four tough questions about patient data that hospitals must answer How Cambridge Analytica's use of Facebook data highlights ambiguities

New study finds value-based care models are bending the cost curve Pure fee-for-service models declining faster than projected

Inspirata acquires GE company Caradigm Will enhance unstructured data processing and speed up CIDT development

The bumpy road to imaging access in rural America How mobile imaging solutions are bringing care to remote regions

Trump moves ahead with tariffs, launches trade war with China Applies to medical imaging equipment and parts

First post-Maria permanent health clinics roll up on Puerto Rican shores Equipped with X-ray and telemedicine capabilities

Provenance and privacy: Healthcare execs talk AI best practices Providers need to understand what the algorithms are doing and how it will help them

IBA to install second US-based Cyclone 70 system in Arizona Supply medical isotopes for diagnosis and treatment of critical diseases

A rural college producing ultrasound experts Behind the scenes at the Oregon Institute of Technology's ultrasound education program

Philips to acquire Remote Diagnostic Technologies The latest in a string of acquisitions for the healthcare company

Courtesy of NorthStar

NorthStar fournira GE Mo-99

par Lauren Dubinsky , Senior Reporter
NorthStar Medical Radioisotopes LLC signed a non-exclusive letter of intent with GE Healthcare on Friday, which entails that NorthStar will supply GE with Molybdenum-99 (Mo-99) when its RadioGenix isotope separation system gets FDA approval. NorthStar also signed a similar agreement with Triad Isotopes, Inc. in June.

"Continuity of supply of 99Mo to meet the growing demand for diagnostic procedures is a key focus for GE Healthcare," Julie Woodland, global product leader at GE, said in a statement. "The company is actively working with new alternative 99mTc sources to help ensure that access to the radioisotope is readily available to aid in the diagnosis of patients both today and in the future."

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



Mo-99 is the parent isotope of Technetium-99m — the most commonly used radioisotope in medical diagnostic imaging. NorthStar is working on creating a domestic source of Mo-99 to ease the constant shortage of it.

"80 percent of the diagnostic nuclear medicine studies performed in the United States today are done with Tc-99m," Ed Fennell, vice president of business development at NorthStar, told DOTmed News. "It's a major component of nuclear medicine."

Almost all Mo-99 is being produced with weapons-useable highly enriched uranium at aging facilities outside of the U.S. Because of that, there have been product shortage and safety and national security concerns.

However, NorthStar will be producing the isotope without using weapons-useable HEU and they only produce a mild amount of waste. Other than quelling the shortage, it was also to help meet the goals set by the U.S. Department of Energy's Global Threat Reduction Initiative.

Those goals aim to lessen and protect vulnerable nuclear and radiological material that's in civilian sites around the world and to reduce the use of HEU in civilian applications.

Fennel said that they are working with all of the major radiopharmacy companies to supply them with Mo-99.

NorthStar expects RadioGenix to receive FDA approval in the last quarter of next year.

Related:


You Must Be Logged In To Post A Comment

Publicité
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS